Casdatifan is a small molecule drug designed to target HIF-2α, and it is being developed for the treatment of neoplasms, urogenital diseases, and digestive system disorders.

Bexagliflozin is a small molecule drug designed to target SGLT2 and is primarily used in the therapeutic areas of endocrinology and metabolic disease.

Empagliflozin is a medication used primarily to treat type 2 diabetes and, in some cases, to help manage heart failure.

When discussing pan-KRAS inhibitors, it’s essential to mention RMC-6236, developed by Revolution Medicines.

BMS-986408 is a small molecule drug developed by Bristol-Myers Squibb Pharmaceuticals Ltd.

we will use the drug Amisulpride as an example to demonstrate how to quickly obtain information about its chemical structure and patent situation using the Patsnap Chemical.

Apixaban is a small molecule drug that targets factor Xa and has been approved for the treatment of various therapeutic areas.

Laroprovstat(AZD-0780) is a small molecule drug developed by AstraZeneca PLC, targeting the PCSK9 protein.

we will use the drug Fulzerasib as an example to demonstrate how to quickly obtain information about its chemical structure and patent situation using the Synapse database and Patsnap Chemical.